Anthony Windebank, M.D., and Nathan Staff, M.D., Ph.D., presented “ALS and Mayo Clinic – A Long History of Partnership in Research and Care” during Mayo Clinic Heritage Days in Rochester, Minn.
Dr. Windebank, professor of neurology and deputy director for discovery in the Mayo Clinic Center for Regenerative Medicine, and Dr. Staff, assistant professor of neurology, are studying the use of mesenchymal stem cells derived from patient adipose (fat) tissue delivered to the spinal fluid of patients with amyotrophic lateral sclerosis (ALS). ALS is often called Lou Gehrig’s disease, after Lou Gehrig, a hall-of-fame baseball player for the New York Yankees who was diagnosed with ALS at Mayo Clinic in 1939.
Watch the presentation, filmed at the Mayo Clinic Research Information Center, below:
New Hope: Stem Cell Trial for ALS Patients